The HER2CLIMB-05 study assessed the efficacy and safety of adding tucatinib to maintenance therapy with trastuzumab/pertuzumab in patients with HER2+ metastatic breast cancer.
Nuralogix's Longevity Mirror has been awarded our Best of CES 2026, thanks to its near-magical features that fits with our ...
Disney Plus will roll out vertical videos later this year, including short-form content, social clips, and AI tools for advertisers.
As it turns out, this is the correct approach. “Heavy dark shades across the entire lid, thick eyeliner, and dramatic cut ...
Discovery Global, its board of directors had begun a review of strategic alternatives to maximize shareholder value, ...
New Year Foodie Fest, The Gabber Book Club, and art show opening receptions: Here's your weekly list of things to do Jan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback